Products

Western blot analysis of human A431 cells treated with calyculin A (100 nM) for 30 min. (lanes 1, 3, & 5) then blots were treated with lambda phosphatase (lanes 2, 4, & 6). The blots were probed with anti-CREB (N-terminal region) (lanes 1 & 2), anti-CREB (Ser-133) (lanes 3 & 4), and anti-CREB (Ser-271) (lanes 5 & 6).

Immunocytochemical labeling of phosphorylated CREB in control and calyculin A-treated A431 cells. The cells were fixed in paraformaldehyde and permeabilized using NP-40 before labeling with rabbit polyclonal CREB (Ser-271). The antibody was detected using goat anti-rabbit DyLight® 594.

PhosphoSolutions Anti-CREB (Ser-271), Phosphospecific Antibody

$340

Immunolabeling of a section of mouse piriform cortex labeled with Anti-Phospho-Ser133 CREB (Cat. p1010-133, red, 1:1000). Cell nuclei are visualized with DAPI DNA stain (blue).

Western blot of rat hippocampal lysate stimulated with forskolin showing specific immunolabeling of the ~45 kDa CREB phosphorylated at Ser133 in the first lane (-). Phosphospecificity is shown in the second lane (+) where immunolabeling is completely eliminated by lysate treatment with lambda phosphatase (λ-Ptase, 800 units/1mg protein for 30 min).

PhosphoSolutions Anti-CREB (Ser133) Antibody

From $160

PhosphoSolutions Anti-CRG-L2 Antibody

$445

Immunofluorescence of HEK293 cells transfected with a fusion construct of GFP with the C-terminal region of S. aureas Cas9 protein (green) that is labeled with Anti-CRISPR Cas9 (Cat. 304-Cas9, 1:1000, red)and the DNA stained blue with DAPI. The yellow label is the overlapping of the Anti-Cas9 antibody and the Cas9-GFP construct.

Western blot of GFP-Cas9 transfected HEK293 cell lysate (+) showing specific immunolabeling of the ~53 kDa GFP-Cas9 fusion protein. Labeling is absent in the untransfected lysate (-).

PhosphoSolutions Anti-CRISPR Cas9 Antibody

From $160

Western blot of human Jurkat cell lysate. The blot was probed with mouse monoclonal anti-Crk II (C-terminal region) antibody at 1:250 (lane 1), 1:500 (lane 2), or 1:1000 (lane 3).

PhosphoSolutions Anti-Crk II (C-terminal region) Antibody

$285

Western blot of human K562 cells stimulated with pervanadate (1 mM) for 30 min. (lanes 1-4). The blot was treated with alkaline phosphatase to dephosphorylate Crk II (lanes 2 & 4), then the blot was probed with mouse monoclonal Crk II (C-terminal region) CM3321 (lanes 1 & 2) and Crk II (Tyr-221) phospho-specific CP4701 (lanes 3 & 4).

PhosphoSolutions Anti-Crk II (Tyr-221), Phosphospecific Antibody

$340

Western blot of human K562 cells stimulated with pervanadate (1 mM) for 30 min. (lanes 1-6). The blot was treated with akaline phosphatase to dephosphorylate Crk (lanes 2, 4 & 6), then the blot was probed with rabbit polyclonals CrkL (C-terminus) CP3081 (lanes 1 & 2), Crk (Tyr-251) phospho-specific CP3091 (lanes 3 & 4), and mouse monoclonal anti-Crk II (C-terminal region) (lanes 5 & 6).

PhosphoSolutions Anti-Crk II (Tyr-251), Phosphospecific Antibody

$340

PhosphoSolutions Anti-CrkL (C-terminus) Antibody

$285

PhosphoSolutions Anti-CrkL (Tyr-207), Phosphospecific Antibody

$340

Western blot image of mouse brain untreated (lanes 1 & 3) or treated with lambda phosphatase (lanes 2 & 4). The blot was probed with anti-CRMP2 (C-terminal Region) (lanes 1 & 2) or anti-CRMP2 (Ser-522) (lanes 3 & 4).

Immunocytochemical labeling of phosphorylated CRMP2 in mouse C2C12 cells. The cells were probed with CRMP2 (C-terminal region) and CRMP2 (Thr-555) rabbit polyclonal antibodies, then the antibodies were detected using appropriate secondary antibodies conjugated to Cy3. The antibodies were used in the absence (left) or presence (right) of their respective blocking peptide (CX2165 or CX2255).

PhosphoSolutions Anti-CRMP2 (C-terminal region) Antibody

$340

Immunocytochemical labeling of CRMP2 phosphorylation in aldehyde-fixed and NP-40-permeabilized NGF-differentiated PC12 cells. The cells were labeled with rabbit polyclonal anti-CRMP2 (Ser-522) (CP2191) antibody in the absence (Left) or presence (Right) of blocking peptide (CX2195). The antibody was detected using appropriate secondary antibody conjugated to DyLight® 594.

PhosphoSolutions Anti-CRMP2 (Ser-522), Phosphospecific Antibody

$340

Western blot of rat PC12 cells untreated (lanes 1 & 3) or treated with calyculin A (lanes 2 & 4). The blot was probed with anti-CRMP2 (C-terminal Region) antibody (lanes 1 & 2) or anti-CRMP2 (Thr-555) antibody (lanes 3 & 4).

PhosphoSolutions Anti-CRMP2 (Thr-555), Phosphospecific Antibody

$340

Western blot of rat PC12 cells stimulated with calyculin A (100 nM) for 30 min (lanes 1-4). Then the blot was treated with lambda phosphatase to dephosphorylate CRMP2 (lanes 2 & 4). The blot was probed with rabbit polyclonal anti-CRMP2 (C-terminal Region) antibody (lanes 1 & 2) or mouse monoclonal anti-CRMP2 (Thr-555) antibody (lanes 3 & 4).

PhosphoSolutions Anti-CRMP2 (Thr-555), Phosphospecific Antibody

$340

PhosphoSolutions Anti-CRTR1 Antibody

$445

Sagittal section of formalin-fixed, paraffin-embedded rat brain showing strong staining for CSPG4/NG2 in the cerebellum, hippocampus and cortex (A-C respectively). Sections were stained with Antibodies Incorporated mouse anti-CSPG4/NG2 (clone 6203-34) antibody at 1:40 dilution and detected with anti-mouse HRP.

Antibodies Incorporated Anti-CSPG4/NG2 Antibody

From $134

Antibodies Incorporated Anti-CSPG4/NG2 Antibody (BSA and Azide free)

$475

Antibodies Incorporated Anti-CSPG4/NG2 Antibody FL490 Conjugate

$474

Antibodies Incorporated Anti-CSPG4/NG2 Antibody FL550 Conjugate

$474

Antibodies Incorporated Anti-CSPG4/NG2 Antibody FL594 Conjugate

$474

Antibodies Incorporated Anti-CSPG4/NG2 Antibody FL650 Conjugate

$474

Western blot of human T47D cell lysate showing specific immunolabeling of the ~100 kDa CtIP phosphorylated at Ser326 in the first lane (-). Phosphospecificity is shown in the second lane (+) where immunolabeling is completely eliminated by blot treatment with lambda phosphatase (λ-Ptase, 1200 units for 30 min).

PhosphoSolutions Anti-CtIP (Ser326) Antibody

From $160

Western blot of human T47D cell lysate showing specific immunolabeling of the ~100 kDa CtIP phosphorylated at Ser327 in the first lane (-). Phosphospecificity is shown in the second lane (+) where immunolabeling is completely eliminated by blot treatment with lambda phosphatase (λ-Ptase, 1200 units for 30 min).

PhosphoSolutions Anti-CtIP (Ser327) Antibody

From $160

Western blot of human T47D cell lysate showing specific immunolabeling of the ~100 kDa CtIP phosphorylated at Thr847 in the first lane (-). Phosphospecificity is shown in the second lane (+) where immunolabeling is completely eliminated by blot treatment with lambda phosphatase (λ-Ptase, 1200 units for 30 min).

PhosphoSolutions Anti-CtIP (Thr847) Antibody

From $160

Western blot analysis of human Jurkat cells treated with 100 nM calyculin A for 30 min. then the blots were untreated (-) or treated (+) with lambda phosphatase. The blots were probed with rabbit polyclonals anti-CXCR4 (Ser-324/Ser-325) (left panel) or anti-CXCR4 (a.a. 322-329) (right panel).

Immunocytochemical labeling of CXCR4 in chick pluripotent cells. The cells were labeled with rabbit polyclonal CXCR4 (a.a. 322-329) antibody (CP4211), then detected using appropriate secondary antibody (Red). (Image provided by Dr. Yangqing Lu at the Regenerative Bioscience Center, University of Georgia).

PhosphoSolutions Anti-CXCR4 (C-terminal region) Antibody

$285

Recover password

Create my account

All products

Recently Viewed